tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
OVID is currently covered by 3 analysts with an average price target of $5.5. This is a potential upside of $3.78 (93.66%) from yesterday's end of day stock price of $2.84.
Ovid Therapeutics's activity chart (see below) currently has 48 price targets and 49 ratings on display. The stock rating distribution of OVID is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 14.92% with an average time for these price targets to be met of 62.43 days.
Highest price target for OVID is $7, Lowest price target is $4, average price target is $5.5.
Most recent stock forecast was given by from WEDBUSH on 15-Apr-2026. First documented stock forecast 30-May-2017.
Currently out of the existing stock ratings of OVID, 7 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Apr-2024
$7
$4.45 (174.51%)
$7
Buy Since 29-Apr-2024
$4
$1.45 (56.86%)
$2
What is OVID (Ovid Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on OVID (Ovid Therapeutics) with a proven track record?
Which analyst has the most public recommendations on OVID (Ovid Therapeutics)?
Which analyst is the currently most bullish on OVID (Ovid Therapeutics)?
Which analyst is the currently most reserved on OVID (Ovid Therapeutics)?
